Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes Fernando Gomez-PeraltaCristina AbreuGuillermo Umpierrez Practical Approach/CME Article Open access 18 July 2017 Pages: 953 - 962
Erratum to: Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes Fernando Gomez-PeraltaCristina AbreuGuillermo Umpierrez Erratum Open access 23 August 2017 Pages: 963 - 965
Efficacy and Time Sensitivity of Amniotic Membrane treatment in Patients with Diabetic Foot Ulcers: A Systematic Review and Meta-analysis Irakoze LaurentManirakiza AstèreQi Fu Li Review Open access 11 September 2017 Pages: 967 - 979
A Practical Approach to Hypertension Management in Diabetes Altamash Shaikh Review Open access 19 September 2017 Pages: 981 - 989
A Practical Approach to Managing Hypoactive Sexual Desire Disorder in Women with Diabetes Charmaine Rochester-EyeguokanLisa Meade Review Open access 16 September 2017 Pages: 991 - 998
Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study Naoto KatakamiTomoya MitaOn behalf of the UTOPIA study investigators Original Research Open access 01 September 2017 Pages: 999 - 1013
Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden Johan JendleJayne Smith-PalmerStéphane Roze Original Research Open access 04 September 2017 Pages: 1015 - 1030
Costs and Treatment Pathways for Type 2 Diabetes in the UK: A Mastermind Cohort Study Peter EibichAmelia GreenAlastair M. Gray Original Research Open access 06 September 2017 Pages: 1031 - 1045
Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Cohort Study Cheli Melzer CohenBrian Larsen ThorstedAvraham Karasik Original Research Open access 07 September 2017 Pages: 1047 - 1055
Visceral Adipose Tissue as a Risk Factor for Diabetes Mellitus in Patients with Chronic Pancreatitis: A Cross-sectional, Observational Study K. V. S. Hari KumarRahul SharmaA. K. Sood Original Research Open access 11 September 2017 Pages: 1057 - 1064
Healthcare Resource Utilization and Costs Associated with Ketosis Events in Pediatric and Adult Patients with Type 1 Diabetes Mellitus in the UK Nandu ThalangeNatalie Valerie Jane AldhouseJonas Håkan-Bloch Original Research Open access 13 September 2017 Pages: 1065 - 1078
Improved Glycemic Control in a Patient Group Performing 7-Point Profile Self-Monitoring of Blood Glucose and Intensive Data Documentation: An Open-Label, Multicenter, Observational Study Jochen SieberFrank FlackeGuido Freckmann Original Research Open access 14 September 2017 Pages: 1079 - 1085
Systemic Effects of Repeated Intraocular Dexamethasone Intravitreal Implant in Diabetic Patients: A Retrospective Study Alicia Valverde-MegíasPilar Cifuentes-CanoreaJulián García-Feijoo Original Research Open access 16 September 2017 Pages: 1087 - 1096
Relation Between Different Measures of Glycemic Exposure and Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus: An Observational Cohort Study Rients P. T. van WijngaardenJetty A. OverbeekRon M. C. Herings Original Research Open access 18 September 2017 Pages: 1097 - 1109
Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes Feng-fei LiYun ShenJian-hua Ma Original Research Open access 18 September 2017 Pages: 1111 - 1122
Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S) Takuya AwataAkira ShimadaTetsuro Kobayashi Original Research Open access 19 September 2017 Pages: 1123 - 1134
Dose-Dependent Effect of Sitagliptin on Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Post Hoc Analysis Tomoya MitaNaoto KatakamiHirotaka Watada Original Research Open access 20 September 2017 Pages: 1135 - 1146
The Use of Saxagliptin in People with Type 2 Diabetes in France: The Diapazon Epidemiological Study Beverley BalkauBernard CharbonnelBruno Detournay Original Research Open access 25 September 2017 Pages: 1147 - 1162
Detection and Management of Diabetes in England: Results from the Health Survey for England Mimi XiaoCiaran O’Neill Original Research Open access 25 September 2017 Pages: 1163 - 1174
Cost of Glycemic Target Achievement with Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes in the UK Marc EvansSayeed AchhaCheryl Neslusan Original Research Open access 25 September 2017 Pages: 1175 - 1185
Long-Term Follow-Up in a Girl with Cystic Fibrosis and Diabetes Since the First Year of Life Valentina FattorussoAlida CasaleAdriana Franzese Case Report Open access 02 August 2017 Pages: 1187 - 1190
Effect of Liraglutide on Type B Insulin Resistance Syndrome and Insulin Allergy in Type 2 Diabetes: A Case Report Yuko MatsumotoHodaka YamadaKazuo Hara Case Report Open access 23 August 2017 Pages: 1191 - 1194
Erratum to: The Economic Burden of Insulin-Related Hypoglycemia in Spain Witesh ParekhNicki HoskinsPedro Mezquita Raya Erratum Open access 01 September 2017 Pages: 1195 - 1196